General Information of DTT (ID: TTRE6AX)

DTT Name Bcl-x messenger RNA (BCL2L1 mRNA) DTT Info
Gene Name BCL2L1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
Investigative Drug(s)
1 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
PURPUROGALLIN DM63O4F N. A. N. A. Terminated [1]
------------------------------------------------------------------------------------
13 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
4,5-dibenzylbenzene-1,2-diol DMHURXY Discovery agent N.A. Investigative [2]
ISIS 11219 DMW3145 Discovery agent N.A. Investigative [3]
ISIS 11220 DMNJS0K Discovery agent N.A. Investigative [3]
ISIS 11221 DMDUIG3 Discovery agent N.A. Investigative [3]
ISIS 11223 DM7LPI4 Discovery agent N.A. Investigative [3]
ISIS 11224 DMMGA6K Discovery agent N.A. Investigative [3]
ISIS 15998 DMAQ9EB Discovery agent N.A. Investigative [3]
ISIS 15999 DMMEP6J Discovery agent N.A. Investigative [3]
ISIS 16005 DMDORHA Discovery agent N.A. Investigative [3]
ISIS 16009 DMBRKFC Discovery agent N.A. Investigative [3]
ISIS 16010 DMZID0W Discovery agent N.A. Investigative [3]
QEDIIRNIARHLAQVGDSMDR DMJ38YV Discovery agent N.A. Investigative [4]
TW-37 DMDE8YS Discovery agent N.A. Investigative [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Investigative Drug(s)
Molecule Interaction Atlas

References

1 Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J Med Chem. 2003 Sep 25;46(20):4259-64.
2 Vaccinia virus virulence factor N1L is a novel promising target for antiviral therapeutic intervention. J Med Chem. 2010 May 27;53(10):3899-906.
3 US patent application no. 7,148,204, Antisense modulation of bcl-x expression.
4 Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins. J Med Chem. 2006 Oct 19;49(21):6139-42.
5 Fragment-based deconstruction of Bcl-xL inhibitors. J Med Chem. 2010 Mar 25;53(6):2577-88.